TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
B/P-Pharma AB
Closing information (x1000 EUR)
| Closing information | 2025/04 | 2024/04 | 2023/04 |
| Turnover |
1,488
|
1,259
|
1,120 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
15
|
58
|
29 |
| EBITDA |
36
|
76
|
48 |
| Total assets |
533
|
526
|
453 |
| Current assets |
462
|
468
|
381 |
| Current liabilities |
191
|
170
|
129 |
| Equity capital |
325
|
335
|
301 |
| - share capital |
5
|
4
|
4 |
| Employees (average) |
4
|
4
|
3 |
Financial ratios
| Fiscal year | 2025/04 | 2024/04 | 2023/04 |
| Solvency |
61.0%
|
63.7%
|
66.4% |
| Turnover per employee |
372
|
315
|
373 |
| Profit as a percentage of turnover |
1.0%
|
4.6%
|
2.6% |
| Return on assets (ROA) |
2.8%
|
11.0%
|
6.4% |
| Current ratio |
241.9%
|
275.3%
|
295.3% |
| Return on equity (ROE) |
4.6%
|
17.3%
|
9.6% |
| Change turnover |
139
|
180
|
75 |
| Change turnover % |
10%
|
17%
|
7% |
| Chg. No. of employees |
0
|
1
|
0 |
| Chg. No. of employees % |
0%
|
33%
|
0% |
Total value of public sale
| Fiscal year | 2025/04 | 2024/04 | 2023/04 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.